BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 2580616)

  • 1. Lidocaine potentiation of bleomycin A2 cytotoxicity and DNA strand breakage in L1210 and human A-253 cells.
    Lazo JS; Braun ID; Meandzija B; Kennedy KA; Pham ET; Smaldone LF
    Cancer Res; 1985 May; 45(5):2103-9. PubMed ID: 2580616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liblomycin-mediated DNA cleavage in human head and neck squamous carcinoma cells and purified DNA.
    Wassermann K; Zwelling LA; Lown JW; Hartley JA; Nishikawa K; Lin JR; Newman RA
    Cancer Res; 1990 Mar; 50(6):1732-7. PubMed ID: 1689610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of bleomycin-resistant phenotypes of human cell sublines and circumvention of bleomycin resistance by liblomycin.
    Lazo JS; Braun ID; Labaree DC; Schisselbauer JC; Meandzija B; Newman RA; Kennedy KA
    Cancer Res; 1989 Jan; 49(1):185-90. PubMed ID: 2461797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro selection and characterization of a bleomycin-resistant subline of B16 melanoma.
    Zuckerman JE; Raffin TA; Brown JM; Newman RA; Etiz BB; Sikic BI
    Cancer Res; 1986 Apr; 46(4 Pt 1):1748-53. PubMed ID: 2418953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced bleomycin-induced DNA damage and cytotoxicity with calmodulin antagonists.
    Lazo JS; Hait WN; Kennedy KA; Braun ID; Meandzija B
    Mol Pharmacol; 1985 Mar; 27(3):387-93. PubMed ID: 2579318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial single-strand DNA damage and cellular pharmacokinetics of bleomycin A2.
    Lazo JS; Schisselbauer JC; Meandzija B; Kennedy KA
    Biochem Pharmacol; 1989 Jul; 38(13):2207-13. PubMed ID: 2472141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-beta-D-arabinofuranosylcytosine or hydroxyurea in L1210 cells.
    Minford J; Kerrigan D; Nichols M; Shackney S; Zwelling LA
    Cancer Res; 1984 Dec; 44(12 Pt 1):5583-93. PubMed ID: 6208999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection from adriamycin cytotoxicity in L1210 cells by brefeldin A.
    Vichi PJ; Tritton TR
    Cancer Res; 1993 Nov; 53(21):5237-43. PubMed ID: 8106144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of bleomycin cytotoxicity by polyhydric alcohols.
    Suzuki T; Kohda K; Kawazoe Y
    Anticancer Res; 1990; 10(1):97-103. PubMed ID: 1692198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of etoposide-induced DNA damage by calcium antagonists in L1210 cells in vitro.
    Yalowich JC; Ross WE
    Cancer Res; 1984 Aug; 44(8):3360-5. PubMed ID: 6744270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro.
    Bowman KJ; Newell DR; Calvert AH; Curtin NJ
    Br J Cancer; 2001 Jan; 84(1):106-12. PubMed ID: 11139322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Damage and repair induced by bleomycin in the domain of human amplified MYC oncogenes.
    Bianchi NO; Bianchi MS; López-Larraza D; Alitalo K; de la Chapelle A
    Cancer Res; 1990 Apr; 50(8):2379-84. PubMed ID: 1690597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verapamil-induced augmentation of etoposide accumulation in L1210 cells in vitro.
    Yalowich JC; Ross WE
    Cancer Res; 1985 Apr; 45(4):1651-6. PubMed ID: 3978633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of erythrocytes on alveolar macrophage cytostatic activity induced by bleomycin lung damage in rats.
    Huot AE; Gundel RM; Hacker MP
    Cancer Res; 1990 Apr; 50(8):2351-5. PubMed ID: 1690596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen-induced potentiation of DNA damage and cytotoxicity in human breast cancer cells treated with topoisomerase II-interactive antitumor drugs.
    Epstein RJ; Smith PJ
    Cancer Res; 1988 Jan; 48(2):297-303. PubMed ID: 2825970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced cytotoxicity caused by increased DNA strand breakage resulting from synergistic potentiation of bleomycin with Bacillus thuringiensis subsp. israelensis delta-endotoxin.
    Yokoyama Y; Kohda K
    Anticancer Res; 1994; 14(3A):837-40. PubMed ID: 7521154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of hyperthermia with bleomycin and liblomycin: effects on CHO cells in vitro.
    Dogramatzis D; Nishikawa K; Newman RA
    Anticancer Res; 1991; 11(3):1359-64. PubMed ID: 1716087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of etoposide cytotoxicity and DNA strand scission in L1210 and 8226 cells by polyamines.
    Dorr RT; Liddil JD; Gerner EW
    Cancer Res; 1986 Aug; 46(8):3891-5. PubMed ID: 3015379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical modulation of bleomycin induced toxicity.
    Kennedy KA; Hait WN; Lazo JS
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1367-70. PubMed ID: 2428791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the cellular vacuolar system with the cytotoxicity of bleomycin-like agents.
    Lazo JS; Schisselbauer JC; Herring GM; Kennedy KA
    Cancer Commun; 1990; 2(2):81-6. PubMed ID: 1695520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.